253 related articles for article (PubMed ID: 21858008)
1. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.
Keller MJ; Madan RP; Torres NM; Fazzari MJ; Cho S; Kalyoussef S; Shust G; Mesquita PM; Louissaint N; Chen J; Cohen HW; Diament EC; Lee AC; Soto-Torres L; Hendrix CW; Herold BC
PLoS One; 2011 Jan; 6(1):e16475. PubMed ID: 21283552
[TBL] [Abstract][Full Text] [Related]
3. Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.
Thurman AR; Kimble T; Herold B; Mesquita PM; Fichorova RN; Dawood HY; Fashemi T; Chandra N; Rabe L; Cunningham TD; Anderson S; Schwartz J; Doncel G
AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1139-52. PubMed ID: 26204200
[TBL] [Abstract][Full Text] [Related]
4. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
[TBL] [Abstract][Full Text] [Related]
5. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
[TBL] [Abstract][Full Text] [Related]
6. Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study.
Sperling R; Kraus TA; Ding J; Veretennikova A; Lorde-Rollins E; Singh T; Lo Y; Quayle AJ; Chang TL
J Reprod Immunol; 2013 Sep; 99(1-2):80-7. PubMed ID: 23993451
[TBL] [Abstract][Full Text] [Related]
7. Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.
Murphy K; Richardson BA; Dezzutti CS; Marrazzo J; Hillier SL; Hendrix CW; Herold BC
Am J Reprod Immunol; 2015 Oct; 74(4):313-22. PubMed ID: 26094732
[TBL] [Abstract][Full Text] [Related]
8. Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.
Archary D; Liebenberg LJ; Werner L; Tulsi S; Majola N; Naicker N; Dlamini S; Hope TJ; Samsunder N; Abdool Karim SS; Morris L; Passmore JA; Garrett NJ
PLoS One; 2015; 10(7):e0131906. PubMed ID: 26147923
[TBL] [Abstract][Full Text] [Related]
9. Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions.
John GC; Sheppard H; Mbori-Ngacha D; Nduati R; Maron D; Reiner M; Kreiss J
J Acquir Immune Defic Syndr; 2001 Feb; 26(2):170-5. PubMed ID: 11242185
[TBL] [Abstract][Full Text] [Related]
10. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women.
Keller MJ; McGinn AP; Lo Y; Huber A; Espinoza L; Minkoff H; Colie C; Nowicki MJ; D'Souza G; Anastos K
Am J Reprod Immunol; 2016 Jun; 75(6):631-42. PubMed ID: 27145926
[TBL] [Abstract][Full Text] [Related]
12. Lower genital tract cytokine profiles in South African women living with HIV: influence of mucosal sampling.
Jaumdally SZ; Masson L; Jones HE; Dabee S; Hoover DR; Gamieldien H; Langwenya N; Myer L; Todd CS; Passmore JS
Sci Rep; 2018 Aug; 8(1):12203. PubMed ID: 30111808
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation in Genital Tract Soluble Immune Mediators in Postmenopausal Women Is Distinct by HIV Status.
Ghosh M; Jais M; Delisle J; Younes N; Benyeogor I; Biswas R; Mohamed H; Daniels J; Wang C; Young M; Kassaye S
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):251-259. PubMed ID: 30618272
[TBL] [Abstract][Full Text] [Related]
14. Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women.
Mngomezulu K; Mzobe GF; Mtshali A; Osman F; Liebenberg LJP; Garrett N; Singh R; Rompalo A; Mindel A; Karim SSA; Karim QA; Baxter C; Ngcapu S
Front Immunol; 2021; 12():695201. PubMed ID: 34177961
[TBL] [Abstract][Full Text] [Related]
15. Genital self-sampling compared with cervicovaginal lavage for the diagnosis of female genital schistosomiasis in Zambian women: The BILHIV study.
Sturt AS; Webb EL; Phiri CR; Mweene T; Chola N; van Dam GJ; Corstjens PLAM; Wessels E; Stothard JR; Hayes R; Ayles H; Hansingo I; van Lieshout L; Bustinduy AL
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008337. PubMed ID: 32663222
[TBL] [Abstract][Full Text] [Related]
16. Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions.
Kalyoussef S; Nieves E; Dinerman E; Carpenter C; Shankar V; Oh J; Burd B; Angeletti RH; Buckheit KW; Fredricks DN; Madan RP; Keller MJ; Herold BC
PLoS One; 2012; 7(11):e49506. PubMed ID: 23185346
[TBL] [Abstract][Full Text] [Related]
17. Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.
Kissinger PJ; Dumestre J; Clark RA; Wenthold L; Mohammed H; Hagensee ME; Martin DH
Sex Transm Dis; 2005 Apr; 32(4):227-30. PubMed ID: 15788920
[TBL] [Abstract][Full Text] [Related]
18. Impact of reproductive aging on the vaginal microbiome and soluble immune mediators in women living with and at-risk for HIV infection.
Murphy K; Keller MJ; Anastos K; Sinclair S; Devlin JC; Shi Q; Hoover DR; Starkman B; McGillick J; Mullis C; Minkoff H; Dominguez-Bello MG; Herold BC
PLoS One; 2019; 14(4):e0216049. PubMed ID: 31026271
[TBL] [Abstract][Full Text] [Related]
19. Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition.
Jais M; Younes N; Chapman S; Cu-Uvin S; Ghosh M
Am J Obstet Gynecol; 2016 Sep; 215(3):324.e1-324.e10. PubMed ID: 27026477
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cervicovaginal lavage, cervicovaginal lavage enriched with cervical swab, and vaginal tampon for the detection of HIV-1 RNA and HSV-2 DNA in genital secretions.
Delany S; Rosas R; Mlaba N; Clayton T; Akpomiemie G; LeGoff J; Capovilla A; Bélec L; Stevens W; Mayaud P
J Acquir Immune Defic Syndr; 2008 Dec; 49(4):406-9. PubMed ID: 19186353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
